Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES

K-Number: K863874 · 1986-11-13

ApplicantElectro-Nucleonics Laboratories, Inc.
Decision Date1986-11-13
Product CodeCDT
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES is the device name listed in this FDA 510(k) record. The listed applicant is Electro-Nucleonics Laboratories, Inc.. It received FDA 510(k) clearance on 1986-11-13 under 510(k) number K863874. The device is classified under product code CDT. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES?

LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES is a medical device that received FDA 510(k) clearance on 1986-11-13. The listed applicant is Electro-Nucleonics Laboratories, Inc.. The 510(k) number is K863874.

When did LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES receive FDA 510(k) clearance?

LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES received FDA 510(k) clearance on 1986-11-13, under 510(k) number K863874.

Who is the listed applicant for LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES?

The FDA 510(k) record lists Electro-Nucleonics Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES?

The FDA product code for LIPASE HYDROLYSIS/GLYCEROL KINASE, TRIGLYCERIDES is CDT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Electro-Nucleonics Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K873925VIRGO(TM) MEASLES IGG ELISAK873617GEMSTAR II SYSTEMK873416MULTI-ACCESS REAGENT DISPENSERK873358GEMENI URIC ACID U.V.K873088VIRGO(TM) RUBELLA IGG ELISAK871905TOXOPLASMA GONDII IGG ELISA

View all 41 devices →

Related Devices (Code: CDT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K133067ADVIA CHEMISTRY TRIGLYCERIDES_2 (TRIG_2) REAGENTSiemens Healthcare Diagnostics, Inc.K130332VITROS CHEMISTRY PRODUCTS TRIG SLIDESOrtho-Clinical Diagnostics, Inc.K113830VANTERA CLINICAL ANALYZERLiposcienceK102993ELITECH CLINICAL SYSTEMS TRIGLYCERIDES SL, ELITECH CLINICAL SYSTEMS CHOLESTEROL SLSeppim S.A.S.K063804OLYMPUS TRIGLYCERIDE TEST SYSTEMOlympus America, Inc.K043546DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULEDade Behring, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑